Friday, April 14, 2017 11:22:09 PM
However at this point it is IMO too soon to say that the more expensive treatments are better! The HS-110 plus Opdivo results are looking very good so far. We shall soon see how good the HS-110 plus low dose CPA are. Low dose generic CPA would be very inexpensive.
I have no idea how expensive the ComPACT(gp96 plus Ox40)technology is. I would think the combination would be cheaper than the two drugs used separately...and the preclinical indicates that the ComPACT combination is more effective!
And is PTX-25 cost efficient? I have no idea. And what about Shattuck Labs new checkpoint and co-stimulator combination? Might it be cost saving as well?
I have never been a fan of excellent health care for the rich and shabby health care for the poor...if HTBX can help make excellent health care available for all...all the better!
"The refusal of the real is the number one dogma of our time" Rene Girard
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM